DAWN- Day One Biopharmaceuticals, Inc.

Name: Day One Biopharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Day One Biopharmaceuticals, Inc. (DAWN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. DAWN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bender Jeremy	355.0K	$7.64M	-
CFO	York Charles N II	188.0K	$4.05M	-
Other	Vasconcelles Michael	171.0K	$3.68M	-
Other	Dubow Adam	105.0K	$2.26M	-
Other	Merendino Lauren	74.0K	$1.59M	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 7, 2023	Bender Jeremy76	Chief Executive Officer	Sell	12,500	$20.01	$250,113.75	-1.1%	-29.3%	-20.0%
Mar 1, 2023	Grant Julie Papanek78	Director	Sell	25,000	$18.61	$465,302.50	-7.0%	-35.3%	-10.0%
Feb 17, 2023	York Charles N II76	COO, CFO And Secretary	Sell	9,377	$20.03	$187,790.37	-3.5%	-34.8%	-23.5%
Feb 16, 2023	York Charles N II76	COO, CFO And Secretary	Sale+OE	930	$19.57	$18,202.89	-0.3%	-32.5%	-21.6%
Feb 16, 2023	Blackman Samuel C.77	Chief Medical Officer	Sale+OE	674	$19.57	$13,192.20	-	-32.5%	-21.6%
Feb 16, 2023	Bender Jeremy76	Chief Executive Officer	Sale+OE	3,022	$19.57	$59,149.61	-0.3%	-32.5%	-21.6%
Feb 10, 2023	Blackman Samuel C.77	Chief Medical Officer	Sell	10,000	$20.07	$200,659.00	-0.8%	-31.2%	-22.1%
Feb 1, 2023	Grant Julie Papanek78	Director	Sell	25,000	$21.23	$530,794.33	-3.4%	-35.1%	-28.1%
Jan 23, 2023	Bender Jeremy76	Chief Executive Officer	Sell	12,500	$22.00	$274,987.50	-1.0%	-37.1%	-36.9%
Jan 20, 2023	York Charles N II76	COO, CFO And Secretary	Sell	10,000	$22.75	$227,523.00	-3.6%	-42.1%	-38.1%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC